Picture of Pixium Vision SA logo

ALPIX — Pixium Vision SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Pixium Vision: Successful Activation Of Prima System In First U.S. Patient

March 4 (Reuters) - PIXIUM VISION SA  ALPIX.PA :
    * ANNOUNCES PRIMA SYSTEM SUCCESSFUL ACTIVATION IN FIRST
PATIENT IN
US FEASIBILITY STUDY WITH THE NEW GENERATION OF GLASSES
    * SECOND PATIENT HAS ALSO BEEN IMPLANTED AND SHOULD BE
ACTIVATED
SHORTLY
    * SAYS THESE STUDIES WILL SUPPORT UPCOMING PRIMAVERA TRIAL
IN DRY
AMD ON TRACK TO BE FILED IN H1 2020 - CEO
    * SAYS LOOKING FORWARD TO REPORTING IN Q1 2020, 18-MONTH
DATA FROM
PATIENTS IN FRANCE WHO HAVE TRANSITIONED TO NEWEST GENERATION
PRIMA SYSTEM
    * EXPECTS TO START PRIMAVERA IN 2020 WHICH WILL PAVE WAY FOR
REGULATORY APPROVAL," SAYS LLOYD DIAMOND, CHIEF EXECUTIVE
OFFICER OF PIXIUM VISION"

Source text for Eikon:  ID:nGNE88CrWz 
Further company coverage:  ALPIX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))

Recent news on Pixium Vision SA

See all news